Log In
BCIQ
Print this Print this
 

NanoDTPA

  Manage Alerts
Collapse Summary General Information
Company Nanotherapeutics Inc.
DescriptionOral formulation of diethylenetriamine pentacetic acid
Molecular Target
Mechanism of ActionChelating agent
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsTreat radiation exposure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today